Ambac Financial Group (OSG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Achieved 65% year-over-year revenue growth in insurance distribution, with 14.2% organic growth for the year and 8.1% for Q4 2025, driven by organic expansion and acquisitions.
Completed a transformational year, exiting the legacy financial guarantee business and acquiring ArmadaCare, enhancing product diversification and recurring revenue.
Launched 1889 Specialty MGA, expanding into SME financial institutions management liability and leveraging Lloyd's capacity.
Share repurchases totaled $27 million in October, representing 6.7% of shares outstanding.
Financial highlights
Q4 2025 net loss to shareholders was $30 million ($0.84/share), up from $22 million ($0.56/share) in Q4 2024, mainly due to acquisition, exit, and restructuring costs.
Adjusted EBITDA from continuing operations rose to $1.4 million from $0.5 million year-over-year.
Total revenues increased 3% to $67 million for Q4 2025.
Full year 2025 premium production up 50% to $1,312 million; Insurance Distribution premiums up 93% to $952 million.
Insurance Distribution segment net loss improved to $1.4 million from $6 million, with adjusted EBITDA up 33% to just over $7 million.
Outlook and guidance
2026 guidance: insurance distribution organic revenue growth of at least 20% and adjusted EBITDA of ~$40 million.
Specialty insurance segment (Everspan) expected to reach $410 million gross written premiums and $7.5 million adjusted EBITDA.
Consolidated adjusted net income guidance is ~$0.50 per share for 2026.
Management expects strong organic growth in 2026, supported by recent acquisitions, new MGA launches, and cost reduction initiatives.
Expecting 2–4 new MGA launches per year, focusing on scaling recent startups.
Latest events from Ambac Financial Group
- AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025